| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/19/2006 | US20060014243 Human G-protein chemokine receptor HSATU68 |
| 01/19/2006 | US20060014242 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) |
| 01/19/2006 | US20060014241 Extended glucagon-like peptide-1 analogs |
| 01/19/2006 | US20060013901 Compositions comprising flavonoids and tocotrienols and methods thereof |
| 01/19/2006 | US20060013877 Hybrid of itraconazole, cyclosporine or carvedilol with a layered silicate and a process for preparing the same |
| 01/19/2006 | US20060013869 Electrospun amorphous pharmaceutical compositions |
| 01/19/2006 | US20060013861 Functional foods comprising flavonoids and tocotrienols and methods thereof |
| 01/19/2006 | US20060013852 Use of organic compounds |
| 01/19/2006 | CA2572179A1 Enoximone formulations and their use in the treatment of pde-iii mediated diseases |
| 01/19/2006 | CA2571739A1 A composition comprising a pharmacologically active agent coupled to a target cell specific component, and a saponin |
| 01/19/2006 | CA2569888A1 Use of l-carnitine for the treatment of cardiovascular diseases |
| 01/18/2006 | EP1617218A1 METHOD OF SCREENING DRUG WITH THE USE OF 67 kDa LAMININ RECEPTOR AND DRUG OBTAINED THEREBY |
| 01/18/2006 | EP1617216A1 Novel method of screening |
| 01/18/2006 | EP1616957A1 Vector |
| 01/18/2006 | EP1616873A1 Lipid-regulating agent and use thereof |
| 01/18/2006 | EP1616869A1 Substituted porphyrins and their therapeutic use |
| 01/18/2006 | EP1616866A1 M-stage kinesin inhibitor |
| 01/18/2006 | EP1616862A1 Nitrogenous heterocyclic compound and use thereof |
| 01/18/2006 | EP1616856A1 Novel transcriptional factor, process for producing the same and use thereof |
| 01/18/2006 | EP1616576A1 Specific nad(p)h oxidase inhibitor |
| 01/18/2006 | EP1616571A2 Lysine containing peptides for treatment of heart disease |
| 01/18/2006 | EP1616564A2 Manipulation of nitrosative stress for treating microbes and helminths |
| 01/18/2006 | EP1616563A2 Perivascular administration of anti-angiogenic factors for treating or preventing vascular diseases |
| 01/18/2006 | EP1616024A1 The use of pde4d in the screening for medicaments against atherosclerosis |
| 01/18/2006 | EP1616009A2 Method for treatment of angiogenic disorders |
| 01/18/2006 | EP1615952A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2 |
| 01/18/2006 | EP1615936A1 Phosphates of secondary alcohols |
| 01/18/2006 | EP1615932A2 Podophhyllotoxin derivatives as igf-1r inhibitors |
| 01/18/2006 | EP1615890A1 Piperidine derivatives as renin inhibitors for the treatment of hypertension |
| 01/18/2006 | EP1615884A1 Process for the preparation of amorphous calcium salt of atorvastatin |
| 01/18/2006 | EP1615878A2 Compounds, compositions and methods |
| 01/18/2006 | EP1615647A2 Pharmaceutical use of fused 1,2,4-triazoles |
| 01/18/2006 | EP1615630A1 Method for the treatment of diseases linked to an accumulation of triglycerides and cholesterol |
| 01/18/2006 | EP1615612A2 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots |
| 01/18/2006 | EP1470138B1 Mmp inhibitors |
| 01/18/2006 | EP1435951B1 Phenyl substituted 5-membered nitrogen containing heterocycles for the tretment of obesity |
| 01/18/2006 | EP1432683B9 Novel crystalline polymorphic forms of lercanidipine hydrochloride and processes for their preparation |
| 01/18/2006 | EP1412338B1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| 01/18/2006 | EP1404672B1 Tyrosine kinase inhibitors |
| 01/18/2006 | EP1392309A4 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 01/18/2006 | EP1268096B1 Extrusion die |
| 01/18/2006 | EP1232183B1 Peptides having antiangiogenic activity |
| 01/18/2006 | EP1220852B1 Substituted diazepans |
| 01/18/2006 | EP1212335B1 Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1- 4-(2-amin-1-yl-ethoxy)-benzyl]-1h-indol-5-ols |
| 01/18/2006 | EP1210327B1 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 01/18/2006 | EP1210085B1 Pharmaceutical solutions of levosimendan |
| 01/18/2006 | EP1169475B1 Diagnosis of a person's risk for developing diabetic retinopathy |
| 01/18/2006 | EP1028708A4 Topical compositions for prostaglandin e 1? delivery |
| 01/18/2006 | EP0954308B1 Therapeutic treatment for cardiovascular diseases |
| 01/18/2006 | EP0828492B1 Medicaments for preventing intervention-associated stenosis following non-bypass, invasive interventions |
| 01/18/2006 | CN1723210A Fused furan compound |
| 01/18/2006 | CN1723201A Blood-brain barrier disruption inhibitors |
| 01/18/2006 | CN1723196A Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/18/2006 | CN1723193A Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/18/2006 | CN1723019A Compounds having anti-proliferative properties |
| 01/18/2006 | CN1723018A Microtubule stabilisers for treating stenosis in stents |
| 01/18/2006 | CN1723016A Composition functioning to prevent or mitigate symptom or disease attributable to blood vessel aging |
| 01/18/2006 | CN1721412A 7-oxo pyridopyrimidines |
| 01/18/2006 | CN1721403A Water soluble bilirubin and its synthesis process and use |
| 01/18/2006 | CN1720988A Thrombus eliminating, channel activating soft capsule and its preparation method |
| 01/18/2006 | CN1720986A Medicine for treating ischemic cerebrovascular diseases |
| 01/18/2006 | CN1720978A Pulse invigorating injection and method for preparing the same |
| 01/18/2006 | CN1720976A Medicine for treating apoplexy and its complications |
| 01/18/2006 | CN1720968A Medicine for treating cerebrovascular diseases |
| 01/18/2006 | CN1720963A Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and its production process |
| 01/18/2006 | CN1720960A Freeze dried powder injection with red sage root and notoginseng and its preparation process |
| 01/18/2006 | CN1720958A Medicine for treating hyperlipemia, and hypertension and high blood viscosity |
| 01/18/2006 | CN1720957A Blood fat regulating Chinese medicinal composition, its preparation and using method |
| 01/18/2006 | CN1720949A Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and its preparing process |
| 01/18/2006 | CN1720944A Medicine for treating piles and its preparing process |
| 01/18/2006 | CN1720932A Medicine for treating apoplexy |
| 01/18/2006 | CN1720923A Medicine for treating cerebrovascular diseases |
| 01/18/2006 | CN1720920A Sodium aescinate soft capsule and method for preparing the same |
| 01/18/2006 | CN1720912A Pharmaceutical compositions |
| 01/18/2006 | CN1720908A Beta-Asarone transdermal plaster |
| 01/18/2006 | CN1720907A Apoplexy treating injection |
| 01/18/2006 | CN1720905A Application of beta-Asarone in pharmacy |
| 01/18/2006 | CN1237075C Low molecular weight peptide derivatives as inhibitors of laminin/nidogen interaction |
| 01/18/2006 | CN1237071C Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease |
| 01/18/2006 | CN1237062C Ortho-substituted anthranilic acid amides and their use as medicaments |
| 01/18/2006 | CN1237061C Chemokine receptor binding heterocyclic compounds |
| 01/18/2006 | CN1237055C 三唑衍生物 Triazole derivatives |
| 01/18/2006 | CN1237052C Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 01/18/2006 | CN1236831C Compositions for protein delivery via the pulmonary route |
| 01/18/2006 | CN1236804C Making method of capsule for treating hemorrhoid |
| 01/18/2006 | CN1236796C Chinese medicine preparation for lowering blood pressure |
| 01/18/2006 | CN1236792C Brain active effect matter for prevention and treating encephalopathy and developing intelligence and its preparation method |
| 01/18/2006 | CN1236787C Medicine for hemorrhoids |
| 01/18/2006 | CN1236780C Animal cephalin capsule |
| 01/18/2006 | CN1236776C Parabuxinidine pills and preparation thereof |
| 01/18/2006 | CN1236769C Inhibitor for inhibiting cell adhesion |
| 01/18/2006 | CN1236768C Compound blood-pressure reducing medicine |
| 01/18/2006 | CN1236767C Vitronectin receptor antagonists |
| 01/18/2006 | CN1236766C Natural composite preparation for protecting and improving cerebral and heart function and its preparation method |
| 01/18/2006 | CN1236763C Use of an epoxy-sterodal aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects |
| 01/18/2006 | CN1236761C Method to preparing microparticles metoprolol that contain |
| 01/17/2006 | US6987184 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof as JNK inhibitors and compositions and methods related |
| 01/17/2006 | US6987123 A substituted pyrrole-1-yl-alkyloxy-aryl-2-alkyloxypropanoate derivatives, antilipiemic agents, anticholesterol agents |
| 01/17/2006 | US6987120 Pharmaceutical compounds |
| 01/17/2006 | US6987118 peroxisome proliferator activator receptor agonists; anticholesterol, antidiabetic agents; 2-Methyl-2-{2-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazole-5-carbonyl]-1,2,3,4-tetrahydro-isoquinolin-7-yloxy}-propionic acid |